Niagara Falls, ON

Join us in spectacluar Niagara Falls, ON for 3 days of cannabis cultivation, psychedelics and extraction.

September 12-14, 2022

Grow Up Awards Gala

Annual Grow Up Industry Awards. Come celebrate the innovation and sucess in the cannabis growing industry.

September 12, 2022, Niagara Falls

Is It Safe to Smoke DMT?

Jul 14, 2022 | Media Partners, Psychedelic News Wire

This post is presented by our media partner Psychedelic News Wire
View the original article here.

DMT is said to be one of the most potent hallucinogens known to man. Smoking this drug, which is also called the spirit molecule, can cause a range of hallucinations, including visions of alien landscapes, temples, clowns, fairies, sprites, elves and goddesses.

Nick Sand, an underground chemist, discovered in the 1960s that DMT was hallucinogenic when smoked, noting that what the drug opened humans up to was profound. In the 1990s, the drug’s reputation was changed when Terence McKenna, a psychedelic philosopher and author, lectured audiences about the drug’s hyperspaces. This was soon followed by a book on DMT, which was published by Rick Strassman, a clinical associate professor of psychiatry.

Currently, researchers are studying the drug for its therapeutic potential in treating traumatic brain injuries, eating disorders, post-traumatic stress disorder, anxiety and depression. However, even as interest in the drug increases, it remains unclear whether it is safe for consumption through smoking.

Thus far, researchers have discovered that DMT occurs naturally in many animals and plants, including in the human nervous system. However, they note that its presence in the human body doesn’t mean it’s safe to consume.

They have also found that the drug resembles the serotonin molecule closely, noting that the reaction of an individual’s body to the presence of DMT is akin to a neurotoxin’s presence. Researchers explain that the drug is usually present in very small quantities in the body, as its build-up interferes with the serotonin system and causes hallucinations and disorientation, which points to it not being safe for consumption.

Additionally, studies have found that individuals with a history of cardiac abnormalities, heart disease and high blood pressure should refrain from consuming DMT, lest they risk a trip to the ER.

Furthermore, studies have found that if you consume too much vaporized DMT, the drug may interfere with your serotonin system, leading to the serotonin syndrome. This syndrome is brought about by too much serotonin in an individual’s blood stream and is known to cause changes in blood pressure as well as rapid heartbeat, dizziness, nausea, confusion and agitation.

When serotonin levels are extremely high in the body, individuals may experience tremors, blackouts, vomiting, a high fever, twitching and loss of muscle control. In severe cases, inhaled DMT can even cause convulsions and seizures. This is especially likely when individuals have consumed very high doses of vaporized DMT.

Various reports also show that frequent use of DMT can cause paranoia, mania, delusions, psychosis and detachment from reality. Researchers note that mixing other substances with DMT heightens the potential for fatality.

These possible shortcomings of several psychedelic compounds explain why companies such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) are developing medicinal formulations to be administered in a clinical setting only.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

This post was originally published by our media partner here.

UPCOMING EVENTS

O’Cannabiz – June 1-3, 2022
International Convention Centre, Toronto ON

Grow Up – June 20-22, 2022
Victoria Convention Centre, Victoria ON

Grow Up – September 12-14, 2022
Niagara Falls Convention Centre, ON

News from Grow Up Media partners